Biotech Firm's Shares Plummet Amid Planned Pivot to Dogecoin Mining
Dogecoin mining is quite the shift for biotech firm Coeptis Therapeutics, and shareholders don't appear thrilled with the proposed move.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This mining story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
WhiteFiber Inc. agrees to acquire North Carolina property for up to $60M as it pivots from crypto mining to AI data centers
WhiteFiber's pivot to AI data centers highlights a strategic shift in tech infrastructure, emphasizing energy efficiency and rapid...
Riot Platforms signs $9B AI compute deal with Anthropic, shifts from Bitcoin mining
Riot's pivot to AI infrastructure may boost its market value, reflecting a broader trend of rising demand for AI capabilities. The...
Trump Media pivots away from Bitcoin after $360M in digital asset losses
Trump Media's crypto losses highlight the risks of volatile digital assets, prompting a strategic shift towards stabilizing core b...
Paul Tudor Jones' Firm Buys Back Into BlackRock Bitcoin ETF After a Year of Selling
The macro fund raised its iShares Bitcoin Trust stake 18.9% to 688,529 shares worth $22.9 million in Q2, while sharply cutting its...
Citigroup sees potential bond rally as Polymarket odds shift for midterms
A potential bond rally could emerge from political gridlock, affecting fiscal policy and market dynamics, as prediction markets ga...
Goldman Sachs buys $386M in Strategy shares, pushing total stake to $558M
Goldman Sachs' investment in Strategy Inc. highlights growing institutional interest in indirect Bitcoin exposure, potentially inf...